| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药工业(元) | 6,472,432,800.00 | - | 6,146,437,100.00 | 9,839,921,600.00 | 4,789,723,600.00 |
| 医药商业(元) | 6,030,351,000.00 | - | 5,535,604,000.00 | 8,480,450,200.00 | 4,579,838,000.00 |
| 医药工业主营收入(元) | - | 11,079,435,500.00 | - | - | - |
| 医药商业主营收入(元) | - | 10,246,415,300.00 | - | - | - |
| 营业成本(元) | |||||
| 医药工业(元) | 3,793,474,500.00 | - | 3,385,347,900.00 | 5,023,760,300.00 | 2,392,109,800.00 |
| 医药商业(元) | 4,421,842,300.00 | - | 3,851,997,800.00 | 5,855,954,900.00 | 3,205,273,200.00 |
| 医药工业主营收入(元) | - | 5,875,945,700.00 | - | - | - |
| 医药商业主营收入(元) | - | 7,058,370,700.00 | - | - | - |
| 毛利(元) | |||||
| 医药工业(元) | 2,678,958,300.00 | - | 2,761,089,200.00 | 4,816,161,300.00 | 2,397,613,800.00 |
| 医药商业(元) | 1,608,508,700.00 | - | 1,683,606,200.00 | 2,624,495,300.00 | 1,374,564,800.00 |
| 医药工业主营收入(元) | - | 5,203,489,800.00 | - | - | - |
| 医药商业主营收入(元) | - | 3,188,044,600.00 | - | - | - |
| 毛利率(%) | |||||
| 医药工业(%) | 41.39 | - | 44.92 | 48.95 | 50.06 |
| 医药商业(%) | 26.67 | - | 30.41 | 30.95 | 30.01 |
| 医药工业主营收入(%) | - | 46.97 | - | - | - |
| 医药商业主营收入(%) | - | 31.11 | - | - | - |
| 收入构成(%) | |||||
| 医药工业(%) | 51.77 | - | 52.61 | 53.71 | 51.12 |
| 医药商业(%) | 48.23 | - | 47.39 | 46.29 | 48.88 |
| 医药工业主营收入(%) | - | 51.95 | - | - | - |
| 医药商业主营收入(%) | - | 48.05 | - | - | - |
| 毛利构成(%) | |||||
| 医药工业(%) | 62.48 | - | 62.12 | 64.73 | 63.56 |
| 医药商业(%) | 37.52 | - | 37.88 | 35.27 | 36.44 |
| 医药工业主营收入(%) | - | 62.01 | - | - | - |
| 医药商业主营收入(%) | - | 37.99 | - | - | - |